Endocardial unipolar mapping helps identify midmyocardial and epicardial ventricular tachycardia substrate, predict clinical outcomes after ablation, and guide endomyocardial biopsy.
Endocardial unipolar mapping provides valuable diagnostic and prognostic information for managing ventricular tachycardia in patients with structural heart disease.
Epicardial ablation may be required to eliminate ventricular tachycardia (VT) in patients with underlying structural heart disease. The decision to gain epicardial access is frequently based on the suspicion of an epicardial origin for the VT and/or presence of an arrhythmogenic substrate. Epicardial pathology and VT is frequently present in patients with nonischemic right and/or left cardiomyopathies even in the setting of modest or no endocardial bipolar voltage substrate. In this setting, unipolar voltage mapping from the endocardium serves to help identify midmyocardial and/or epicardial VT substrate. The additional value of endocardial unipolar mapping includes its usefulness to predict the clinical outcome after VT ablation, to determine the irreversibility of myocardial disease, and to guide endomyocardial biopsy procedures to specific areas of intramural scarring. In this review, we aim to provide a guide to the use of endocardial unipolar mapping and its appropriate interpretation in a variety of clinical situations.
Bazán et al. (Mon,) conducted a review in Ventricular tachycardia in structural heart disease. Endocardial unipolar electroanatomic mapping was evaluated. Endocardial unipolar mapping helps identify midmyocardial and epicardial ventricular tachycardia substrate, predict clinical outcomes after ablation, and guide endomyocardial biopsy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: